Oncovalent Therapeutics
Developer of Immuno oncology drugs intended to develop novel therapeutics to inhibit the human oncogene.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Oncovalent Therapeutics Information
Geographic Data
Address:
City: Thousand Oaks
State: California
Zip:
Country: United States
Financial Info
Stage:
undisclosed
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Developer of Immuno oncology drugs intended to develop novel therapeutics to inhibit the human oncogene. The company develops small molecule drugs that are orally available and straightforward to synthesize used for aggressive lymphoma and colorectal cancers, thereby providing clients with products to address unmet medical needs.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Funding Round | 1 | - |
Corner Ventures Corner Ventures |
9/2020 | Funding Round | 1 | - |
Corner Ventures Corner Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
